SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-022978
Filing Date
2019-06-20
Accepted
2019-06-20 16:41:29
Documents
109
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 20-F taro-20f_20190331.htm 20-F 5365737
2 EX-12.1 taro-ex121_7.htm EX-12.1 16992
3 EX-12.2 taro-ex122_6.htm EX-12.2 17026
4 EX-13 taro-ex13_8.htm EX-13 11085
  Complete submission text file 0001564590-19-022978.txt   16503704

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT taro-20190331.xml EX-101.INS 3927534
6 XBRL TAXONOMY EXTENSION SCHEMA taro-20190331.xsd EX-101.SCH 101425
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE taro-20190331_cal.xml EX-101.CAL 110275
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE taro-20190331_def.xml EX-101.DEF 236723
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE taro-20190331_lab.xml EX-101.LAB 670353
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE taro-20190331_pre.xml EX-101.PRE 500268
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000906338 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 001-35463 | Film No.: 19908977
SIC: 2834 Pharmaceutical Preparations